# MicroPort and Robocath to form China joint venture for vascular robotics

MicroPort and Robocath signed a binding term sheet to establish a China-based joint venture to obtain regulatory approval, manufacture, and commercialize Robocath's R-One robotic system in Greater China. MicroPort will invest €5.1 million for 51% stake, Robocath €4.9 million for 49%.

- Type: Partnership
- Announced: 2020-04-23
- Where: China, China
- Value: $10.9M (10.0M EUR)
- Status: announced
- Products: vascular robotic system, R-One
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md), [Automation and Robotics](https://endata.com/sectors/automation-robotics.md)

## Companies

- [MicroPort Medical](https://endata.com/companies/30166.md) (partner)
- [Robocath](https://endata.com/companies/46844.md) (partner)

## Sources

- [zhitongcaijing.com](https://www.zhitongcaijing.com/content/detail/297521.html), 2020-04-29: "The investment and joint venture enable the Group to become a shareholder of Robocath, thereby promoting cooperation with Robocath to commercialize its highly innovative vascular robotic platform in the Chinese market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.